KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Operating Leases (2019 - 2025)

Idexx Laboratories (IDXX) has 7 years of Operating Leases data on record, last reported at $128.2 million in Q4 2025.

  • For Q4 2025, Operating Leases rose 31.06% year-over-year to $128.2 million; the TTM value through Dec 2025 reached $128.2 million, up 31.06%, while the annual FY2025 figure was $128.2 million, 31.06% up from the prior year.
  • Operating Leases reached $128.2 million in Q4 2025 per IDXX's latest filing, down from $133.1 million in the prior quarter.
  • Across five years, Operating Leases topped out at $133.5 million in Q2 2025 and bottomed at $87.4 million in Q4 2021.
  • Average Operating Leases over 5 years is $110.1 million, with a median of $108.9 million recorded in 2021.
  • Peak YoY movement for Operating Leases: soared 56.81% in 2021, then dropped 10.91% in 2023.
  • A 5-year view of Operating Leases shows it stood at $87.4 million in 2021, then rose by 15.86% to $101.2 million in 2022, then dropped by 1.55% to $99.7 million in 2023, then decreased by 1.84% to $97.8 million in 2024, then skyrocketed by 31.06% to $128.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Operating Leases were $128.2 million in Q4 2025, $133.1 million in Q3 2025, and $133.5 million in Q2 2025.